Search

everythinglearnresearchcommunity

for

Search:↓

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Apremilast did not work for treating severe alopecia areata.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.

OXI1 kinase is essential for plant defense and root hair growth in Arabidopsis.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

Early diagnosis and lifelong zinc supplementation are crucial for treating acrodermatitis enteropathica effectively.

A single steroid injection can cause serious side effects like Cushing Syndrome.

Phenolic compounds from Quercus acutissima leaves, especially casuarinin, may help treat acne.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

A Chinese man with KID syndrome had a new mutation in the GJB2 gene.

The optimized Cinchonine gel effectively fights acne bacteria and is safe for twice-daily use.

Lower MC2R expression may contribute to alopecia areata.

A specific DNA region controls skin cell gene expression by working with certain proteins.

Involucrin is crucial for skin cell maturation and protection.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

ADAM 10 and ADAM 12 proteins are involved in different stages of hair growth and could be targets for treating hair disorders.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Early diagnosis and nutritional support are crucial for managing Cronkhite-Canada Syndrome.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Overexpression of ALK2 in hair follicles disrupts skin development and slows wound healing.